{"name":"Bosnalijek D.D","slug":"bosnalijek-d-d","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Lysobact Complete Sprey","genericName":"Lysobact Complete Sprey","slug":"lysobact-complete-sprey","indication":"Treatment of various skin and soft tissue infections","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Pharyngal® Oromucosal Spray","genericName":"Pharyngal® Oromucosal Spray","slug":"pharyngal-oromucosal-spray","indication":"Relief of pain in the throat","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Tantum Verde® Spray","genericName":"Tantum Verde® Spray","slug":"tantum-verde-spray","indication":"Relief of heartburn and indigestion","status":"phase_3"}]}],"pipeline":[{"name":"Lysobact Complete Sprey","genericName":"Lysobact Complete Sprey","slug":"lysobact-complete-sprey","phase":"phase_3","mechanism":"Lysobact Complete Sprey is a broad-spectrum antibiotic spray.","indications":["Treatment of various skin and soft tissue infections"],"catalyst":""},{"name":"Pharyngal® Oromucosal Spray","genericName":"Pharyngal® Oromucosal Spray","slug":"pharyngal-oromucosal-spray","phase":"phase_3","mechanism":"Pharyngal Oromucosal Spray is a local anesthetic used to relieve pain in the throat.","indications":["Relief of pain in the throat"],"catalyst":""},{"name":"Tantum Verde® Spray","genericName":"Tantum Verde® Spray","slug":"tantum-verde-spray","phase":"phase_3","mechanism":"Tantum Verde is an antacid that works by neutralizing stomach acid.","indications":["Relief of heartburn and indigestion"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPUTlqQkdHWEFJZ0dLbkFyR1dMcThqcFNJcEJtMDJhNi1zMkFncE91SUxlWGp6NHN1bjlQQ1BTUllKUGlnNk5qNEJkMDg1S0JBN25FN3NrVnQxa1RzeXlkaC1rNDhROF93Vm9VcS1BYlRuZFFndDZEUGpwSkxuMTl1eHJyWlEwWUVGN0xqS1FENTNSTnBJMHc?oc=5","date":"2025-05-19","type":"deal","source":"SeeNews","summary":"Bosnia's AS submits takeover offer for drugmaker Bosnalijek | Bosnia and Herzegovina Deals News - SeeNews","headline":"Bosnia's AS submits takeover offer for drugmaker Bosnalijek | Bosnia and Herzegovina Deals News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNSW9WMHhyR2tqOC1wYWVWSUFNeW55cnQxUGROel9YVFlVNGpCOG83cXhFZUlsM2hzZjJ4RHg5Njlmall5ZkQ5UUptajBNemZiZ2kzVU9Qc3lCMV9WdTV3YzFoZnBIX05lbjl1SjVReVZTSlp3TTZSUEZSVG1JODRDMmpQSGZZaTA?oc=5","date":"2025-05-07","type":"earnings","source":"SeeNews","summary":"Bosnia's Bosnalijek turns to net profit y/y in Q1 | Bosnia and Herzegovina Company News - SeeNews","headline":"Bosnia's Bosnalijek turns to net profit y/y in Q1 | Bosnia and Herzegovina Company News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOcUZuRXhPWWRta1RjQU13X2c5cC0td25DcFZHN00tM3JCZTRTRl8wemZfV3UyYzNtOG9rUnVTOTVhdHBYSDc2a1I0azZQVVBIRXNabGdBdjVLcFRQUHQzNXVSMWd5d1FMOExiNkhYZ0NxWE5xQzNNWGhpdHhCRmNhVkdYWWZiNXZiX2tPY21vcGVWdw?oc=5","date":"2025-04-02","type":"pipeline","source":"Transparency.org","summary":"The Bosnalijek case: Misappropriation of funds - Transparency.org","headline":"The Bosnalijek case: Misappropriation of funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQWlltSHhxQ3FDZHVBU0YwUkVobXNESDR3ZkltU05Pbk56b1JWeWlrUDc1elhONmVNUkRjTHB1dmtwQ3gwQ25VM05UQ1lqNGdiWDVFTmNtRWVkODJLWTZhQW1YS1BXU1NPc3lDblJBaXZmSklNV1BNT0xUUlZuZlJEelctMnBrSHpraTluRGdoUV9KZw?oc=5","date":"2025-03-17","type":"earnings","source":"SeeNews","summary":"Bosnia's Bosnalijek 2024 net profit climbs 23% y/y | Bosnia and Herzegovina Company News - SeeNews","headline":"Bosnia's Bosnalijek 2024 net profit climbs 23% y/y | Bosnia and Herzegovina Company News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNaTk2ZE5Wd3k4X1JneXZPUjcta0p4VlFzWS1rR3VHeHZON2tiRWVYeWpiM0NGZTcwc01VQlhkQUplUHNQbzVPM1RiVndWQUh3b3ltanNRcmtQTUxSajRpWWpMUEN6TWVPUmNxdzN5S19uSDNPaXc0QmZHVGY5NzI4d3dmeGRqam4wRmczajJlVUw3TUIt?oc=5","date":"2025-03-03","type":"pipeline","source":"SeeNews","summary":"Consortium to submit bid for Bosnian drugmaker Bosnalijek - SeeNews","headline":"Consortium to submit bid for Bosnian drugmaker Bosnalijek","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOdmtsZGJvMmh1YjBjR1FtSzh3WmNSdzhjb3JfOFpmX0M0T0Y1aEdjSG5kRFAxeC1pZkxtei0yZG5xSVlPT0pjbzZmOXIyeFNhSEJLMU9JemtmdjNEOWxUZ3ozMHhGNmozc25JMU1CZVZLUU4xN3hDNmRmcGdlZ29PRld2R21fWjFlNkNrZGM5cWxybjVFTjVuSGhoOVdKcEhXaG92TDVsMHdmdmxIdlHSAa4BQVVfeXFMTnZrbGRibzJodWIwY0dRbUs4d1pjUnc4Y29yXzhaZl9DNE9GNWhHY0huZERQMXgtaWZMbXotMmRucUlZT09KY282ZjlyMnhTYUhCSzFPSXprZnYzRDlsVGd6MzB4RjZqM3NuSTFNQmVWS1FOMTd4QzZkZnBnZWdvT0ZXdkdtX1oxZTZDa2RjOXFscm41RU41bkhoaDlXSnBIV2hvdkw1bDB3ZnZsSHZR?oc=5","date":"2023-09-21","type":"pipeline","source":"Sarajevo Times","summary":"Edin Arslanagic and Others were sentenced to 39 Years in Prison in ‘Bosnalijek’ Case - Sarajevo Times","headline":"Edin Arslanagic and Others were sentenced to 39 Years in Prison in ‘Bosnalijek’ Case","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOZ1VtT2k2VktnOFpmcVhXaHVUaTZNV1piMDZuS0FuczJQdjhoMmsyLTBNMXFtWW5RVDUxZWg4X1BRR0NqbDBESGdKRjBDemlzUjRpaTJ0N3QzSTlsV3VCempqTlk5MjUxblNvOFNJMUFheWphaUpzaFlkZnFQXzM4RHpRNmZjU2Y0N29ZWURQRE8?oc=5","date":"2023-03-23","type":"earnings","source":"SeeNews","summary":"Bosnian drug maker Bosnalijek grows net profit in 2022 - SeeNews","headline":"Bosnian drug maker Bosnalijek grows net profit in 2022","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOTjFHSUVCRHJPUFBWeG0wYUZBMEdRNmdzSmxyVURMQzUycHNjNHIwZnY1RUd0aVYtcjlKNmFHVW5ESzVSNVFXbGRsRVZMMVlVQ2VxZURMbEd2TnhIaTVRS1U1SVYtWENOYk9JOFlWWXQwYjZQbVVmT2JCbHV3ellDdy1EZ3huS0JCeWE3cDJFTkM3dkV4Rmh5THFLOU9oa1E?oc=5","date":"2021-12-20","type":"pipeline","source":"SeeNews","summary":"Bosnian drug maker Bosnalijek appoints Adnan Hadzic as interim GM - SeeNews","headline":"Bosnian drug maker Bosnalijek appoints Adnan Hadzic as interim GM","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNTzhXMmFlQlVoRkJwcGp2SEJXd0ptclhRaFprSnVFLWM2ay1LbjJEMFVhTjNVZFV2TG4tMVI2R01IV012T05xVlppRk1IYlhWWDh1WksxWFRQYXp3NzhOdGtNNmxMcE8xVG9DdThWWm56YjFPR3ZKNjRWVVoxWTlWZUhKeFJkSGc1Ym5NdWlYRUE0REpjQmdDaTJtdw?oc=5","date":"2021-12-07","type":"pipeline","source":"SeeNews","summary":"Bosnian drug maker Bosnalijek's general manager arrested - report - SeeNews","headline":"Bosnian drug maker Bosnalijek's general manager arrested - report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQSUxENS1KZ1dmUmEzVzg2eTNyMno2d20yZFpzR3gwc0dFRWNVOEdicGdVa0dabGo2aXc0eWtEbGNhTlAwVDdHZGxLUXJlck95MHN3MURjSlFXM2xBVHlrVk8wbHpseDNGRE52U25QWFpNeWhTZVVuZzljUmsxMEt1dUwtR1lZN0RZaF9IdG5td2JWdVotSDU0VDVTcFBPWXc?oc=5","date":"2016-04-21","type":"pipeline","source":"Organized Crime and Corruption Reporting Project | OCCRP","summary":"Suspicious transactions on the Moldovan-Bosnian drug market - Organized Crime and Corruption Reporting Project | OCCRP","headline":"Suspicious transactions on the Moldovan-Bosnian drug market - Organized Crime and Corruption Reporting Project | OCCRP","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":3},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}